Do GWAS-Identified Risk Variants for Chronic Lymphocytic Leukemia Influence Overall Patient Survival and Disease Progression? Int J Mol Sci
An Integrated Workflow to Study the Promoter-Centric Spatio-Temporal Genome Architecture in Scarce Cell Populations JOVE-J VIS EXP
Time trends and survival of marginal zone lymphoma over 25 years in Girona, Spain (1994-2018) CANCER MED-US
An epigenetic switch controls an alternative NR2F2 isoform that unleashes a metastatic program in melanoma Nat Commun
Iron overload refractory to phlebotomy in a patient with type 1 hereditary hemochromatosis MED CLIN-BARCELONA
Mafosfamide, a cyclophosphamide analog, causes a proinflammatory response and increased permeability on endothelial cells in vitro BONE MARROW TRANSPL
Immune-interacting lymphatic endothelial subtype at capillary terminals drives lymphatic malformation J EXP MED
Survival of patients with mantle cell lymphoma in the rituximab era: Retrospective binational analysis between 2000 and 2020 BRIT J HAEMATOL